# Thalassemic Iron Overload Cardiomyopathy is Ameliorated by Taurine Supplementation

> **NCT04291352** · NA · UNKNOWN · sponsor: **University Health Network, Toronto** · enrollment: 60 (estimated)

## Conditions studied

- Thalassemia Major

## Interventions

- **DIETARY_SUPPLEMENT:** Taurine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04291352
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-01
- **Primary completion:** 2024-10-31
- **Final completion:** 2025-10-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04291352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04291352, "Thalassemic Iron Overload Cardiomyopathy is Ameliorated by Taurine Supplementation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04291352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*